Frankfurt - Delayed Quote EUR
Aurinia Pharmaceuticals Inc. (IKAP.F)
7.06
+0.07
+(0.97%)
At close: April 25 at 9:39:01 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BAILEY JEFFREY ALLEN Director | Stock Award(Grant) | Nov 21, 2024 | 25,491 |
| DONLEY MATTHEW MAXWELL Chief Operating Officer | Sale | Mar 4, 2025 | 680,465 |
| GREENLEAF PETER S Chief Executive Officer | Sale | Mar 4, 2025 | 1,788,940 |
| JAYNE DAVID ROLAND WALKER Director | Stock Award(Grant) | Nov 21, 2024 | 56,499 |
| JOHNSON CRAIG A Director | Stock Award(Grant) | Nov 21, 2024 | 20,631 |
| KEENAN GREG Officer | Sale | Mar 7, 2025 | 153,484 |
| MILLER JOSEPH M Chief Financial Officer | Sale | Mar 4, 2025 | 577,361 |
| ROBERTSON STEPHEN P General Counsel | Sale | Mar 4, 2025 | 509,276 |
| SMITH KAREN LESLEY M.D. PH.D. Director | Stock Award(Grant) | Nov 21, 2024 | 24,807 |
| TANG KEVIN C Director | Purchase | Mar 4, 2025 | -- |